Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Marina Caks"'
Autor:
Urska Janzic, Andrej Janzic, Abed Agbarya, Urska Bidovec-Stojkovic, Katja Mohorcic, Marina Caks, Peter Korosec, Matija Rijavec, Erik Skof
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 535 (2024)
Due to the devastating COVID-19 pandemic, a preventive tool in the form of vaccination was introduced. Thoracic cancer patients had one of the highest rates of morbidity and mortality due to COVID-19 disease, but the lack of data about the safety and
Externí odkaz:
https://doaj.org/article/5de58b0a87b34b86add7f954bc71968c
Autor:
Urska Janzic, Urska Bidovec-Stojkovic, Peter Korosec, Katja Mohorcic, Loredana Mrak, Marina Caks, Maja Ravnik, Erik Skof, Matija Rijavec
Publikováno v:
Vaccines, Vol 11, Iss 6, p 1017 (2023)
Background: The recommended booster third dose of vaccination against COVID-19 in cancer patients seems reasonable to protect them against a severe disease course. A prospective study was designed to assess the immunogenicity, efficacy, and safety of
Externí odkaz:
https://doaj.org/article/261d440f6a5543cb8bf49f92756fe42e
Autor:
Urska Janzic, Urska Bidovec-Stojkovic, Katja Mohorcic, Loredana Mrak, Nina Fokter Dovnik, Marija Ivanovic, Maja Ravnik, Marina Caks, Erik Skof, Jerneja Debeljak, Peter Korosec, Matija Rijavec
Publikováno v:
Future oncology, pp. 1-10, 2022.
Because cancer patients are especially endangered by SARS-CoV-2 infection and have worse disease course and outcomes, it is crucial to protect them from this infection. This study was aimed at assessing protective antibodies after patients received m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d509e621dcca3de6ff9855bdd027b91
https://dirros.openscience.si/IzpisGradiva.php?id=15227
https://dirros.openscience.si/IzpisGradiva.php?id=15227
Autor:
Urska Janzic, Urska Bidovec-Stojkovic, Katja Mohorcic, Loredana Mrak, Nina Fokter Dovnik, Marija Ivanovic, Maja Ravnik, Marina Caks, Erik Skof, Jerneja Debeljak, Peter Korosec, Matija Rijavec
Background: SARS-CoV-2 vaccination in cancer patients is crucial since they are at increased risk of severe COVID-19 disease course, but data on efficacy and safety of vaccination are scarce.Methods: We performed a prospective observational study of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::102e25335e4e4c0e321d67133f6416e7
https://doi.org/10.21203/rs.3.rs-1185527/v1
https://doi.org/10.21203/rs.3.rs-1185527/v1
Autor:
Urska Janzic, Urska Bidovec-Stojkovic, Mohorcic Katja, Nina Fokter Dovnik, Marina Caks, Jerneja Debeljak, Peter Korosec, Matija Rijavec
Publikováno v:
Journal of Clinical Oncology. 40:e18791-e18791
e18791 Background: Since cancer patients (pts) are at increased risk of severe morbidity and mortality due to COVID-19, SARS-CoV-2 vaccination is crucial to prevent severe disease course. The efficacy and longevity of vaccine protection, however, is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eb72e2a87bf261eac12c446faa01dc9
https://doi.org/10.1200/jco.2022.40.16_suppl.e18791
https://doi.org/10.1200/jco.2022.40.16_suppl.e18791
Autor:
Erika Matos, Snežana Đokić, Srdjan Novaković, Marina Čakš, Rok Devjak, Nežka Hribernik, Kaja Cankar
Publikováno v:
Onkologija, Vol 28, Iss 1 (2024)
Rak neznanega izvora (RNI) je opredeljen kot karcinom ali nediferencirana neoplazma, pri kateri z naborom standardnih diagnostičnih postopkov ni mogoče odkriti izvornega mesta bolezni. Tradicionalno RNI delimo v dve podskupini, pri čemer le pribli
Externí odkaz:
https://doaj.org/article/35c287721c644600a2a2020d3dd09923
Autor:
Martina Vrankar, Nina Boc, Izidor Kern, Aleš Rozman, Karmen Stanič, Tomaž Štupnik, Mojca Unk, Maja Ebert Moltara, Vesna Zadnik, Katja Adamič, Jernej Benedik, Marko Bitenc, Jasna But Hadžić, Anton Crnjac, Marina Čakš, Dominik Časar, Eva Ćirić, Tanja Čufer, Ana Demšar, Rok Devjak, Goran Gačevski, Marta Globočnik Kukovica, Kristina Gornik Kramberger, Maja Ivanetič Pantar, Marija Ivanovič, Urška Janžič, Staša Jelerčič, Veronika Kloboves Prevodnik, Mile Kovačevič, Luka Ležaić, Mateja Marc Malovrh, Katja Mohorčič, Loredana Mrak, Igor Požek, Nina Turnšek, Bogdan Vidmar, Dušanka Vidovič, Gregor Vlačič, Ana Lina Vodušek, Rok Zbačnik, Ivana Žagar
Publikováno v:
Onkologija, Vol 27, Iss 1 (2023)
In 2019, the Recommendations for the management of patients with lung cancer were published bringing much-needed standardisation of diagnosis and treatment to improve survival of patients with lung cancer. Three years after the original Recommendatio
Externí odkaz:
https://doaj.org/article/3b1270e9772f48a88ef104c12d74f549
Autor:
ANJA KOVAČ, Erika Matos, Cvetka Grašič Kuhar, Marina Čakš, Tanja Ovčariček, Marina Mencinger, Mojca Humar, Simona Borštnar
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss , Pp 100201- (2020)
Background: Selective cyclin-dependent kinases 4/6 inhibitors (CDKi) have become the standard of care in patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancer (ABC). We performed retrospective analysis in patients treated
Externí odkaz:
https://doaj.org/article/c7467637b3a9492d8d06b04ddfa13ccb